Waters Corporation (WAT)

$354.4

-0.65

(-0.18%)▲

Market is closed - opens 7 PM, 04 Oct 2024

Performance

  • $351.33
    $357.89
    $354.40
    downward going graph

    0.87%

    Downside

    Day's Volatility :1.84%

    Upside

    0.98%

    downward going graph
  • $231.90
    $367.21
    $354.40
    downward going graph

    34.57%

    Downside

    52 Weeks Volatility :36.85%

    Upside

    3.49%

    downward going graph

Returns

PeriodWaters CorporationSector (Health Care)S&P500
3 Months
25.18%
7.5%
3.1%
6 Months
5.51%
6.9%
9.6%
1 Year
35.8%
20.9%
35.0%
3 Years
3.55%
21.0%
31.0%

Highlights

Market Capitalization
21.4B
Book Value
$23.79
Earnings Per Share (EPS)
10.01
PE Ratio
35.95
PEG Ratio
3.74
Wall Street Target Price
341.3
Profit Margin
20.71%
Operating Margin TTM
26.7%
Return On Assets TTM
11.17%
Return On Equity TTM
54.57%
Revenue TTM
2.9B
Revenue Per Share TTM
48.45
Quarterly Revenue Growth YOY
-4.3%
Gross Profit TTM
1.7B
EBITDA
995.2M
Diluted Eps TTM
10.01
Quarterly Earnings Growth YOY
-0.06
EPS Estimate Current Year
11.6
EPS Estimate Next Year
12.72
EPS Estimate Current Quarter
2.56
EPS Estimate Next Quarter
2.89

Analyst Recommendation

Hold
    0
    0%Buy
    77%Hold
    22%Sell
Based on 27 Wall street analysts offering stock ratings for Waters Corporation(by analysts ranked 0 to 5 stars)
Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
21
20
20
Sell
6
6
6

Analyst Forecast

What analysts predicted

Downside of 3.7%

Current $354.40
Target $341.30

Company Financials

FY18Y/Y Change
Revenue
2.4B
↑ 4.8%
Net Income
593.8M
↑ 2823.51%
Net Profit Margin
24.54%
↑ 23.66%
FY19Y/Y Change
Revenue
2.4B
↓ 0.55%
Net Income
592.2M
↓ 0.27%
Net Profit Margin
24.61%
↑ 0.07%
FY20Y/Y Change
Revenue
2.4B
↓ 1.71%
Net Income
521.6M
↓ 11.93%
Net Profit Margin
22.05%
↓ 2.56%
FY21Y/Y Change
Revenue
2.8B
↑ 17.78%
Net Income
692.8M
↑ 32.84%
Net Profit Margin
24.87%
↑ 2.82%
FY22Y/Y Change
Revenue
3.0B
↑ 6.68%
Net Income
707.8M
↑ 2.15%
Net Profit Margin
23.81%
↓ 1.06%
FY23Y/Y Change
Revenue
3.0B
↓ 0.52%
Net Income
642.2M
↓ 9.26%
Net Profit Margin
21.72%
↓ 2.09%
Q1 FY23Q/Q Change
Revenue
684.7M
↓ 20.25%
Net Income
140.9M
↓ 37.94%
Net Profit Margin
20.58%
↓ 5.87%
Q2 FY23Q/Q Change
Revenue
740.6M
↑ 8.16%
Net Income
150.6M
↑ 6.83%
Net Profit Margin
20.33%
↓ 0.25%
Q3 FY23Q/Q Change
Revenue
711.7M
↓ 3.9%
Net Income
134.6M
↓ 10.63%
Net Profit Margin
18.91%
↓ 1.42%
Q4 FY23Q/Q Change
Revenue
819.5M
↑ 15.14%
Net Income
216.2M
↑ 60.69%
Net Profit Margin
26.38%
↑ 7.47%
Q1 FY24Q/Q Change
Revenue
636.8M
↓ 22.29%
Net Income
102.2M
↓ 52.73%
Net Profit Margin
16.05%
↓ 10.33%
Q2 FY24Q/Q Change
Revenue
708.5M
↑ 11.26%
Net Income
142.7M
↑ 39.67%
Net Profit Margin
20.15%
↑ 4.1%
FY18Y/Y Change
Total Assets
3.7B
↓ 30.19%
Total Liabilities
2.2B
↓ 30.44%
FY19Y/Y Change
Total Assets
2.6B
↓ 31.4%
Total Liabilities
2.8B
↑ 28.39%
FY20Y/Y Change
Total Assets
2.8B
↑ 11.06%
Total Liabilities
2.6B
↓ 5.97%
FY21Y/Y Change
Total Assets
3.1B
↑ 8.98%
Total Liabilities
2.7B
↑ 4.59%
FY22Y/Y Change
Total Assets
3.3B
↑ 6.03%
Total Liabilities
2.8B
↑ 1.82%
FY23Y/Y Change
Total Assets
4.6B
↑ 41.0%
Total Liabilities
3.5B
↑ 25.19%
Q1 FY23Q/Q Change
Total Assets
3.3B
↑ 0.77%
Total Liabilities
2.7B
↓ 2.52%
Q2 FY23Q/Q Change
Total Assets
4.5B
↑ 37.54%
Total Liabilities
3.8B
↑ 39.53%
Q3 FY23Q/Q Change
Total Assets
4.5B
↓ 1.12%
Total Liabilities
3.6B
↓ 4.91%
Q4 FY23Q/Q Change
Total Assets
4.6B
↑ 2.88%
Total Liabilities
3.5B
↓ 3.21%
Q1 FY24Q/Q Change
Total Assets
4.5B
↓ 2.55%
Total Liabilities
3.3B
↓ 6.45%
Q2 FY24Q/Q Change
Total Assets
4.4B
↓ 1.33%
Total Liabilities
3.0B
↓ 6.62%
FY18Y/Y Change
Operating Cash Flow
604.4M
↓ 13.36%
Investing Cash Flow
1.7B
↓ 414.19%
Financing Cash Flow
-2.1B
↑ 3218.55%
FY19Y/Y Change
Operating Cash Flow
643.1M
↑ 6.39%
Investing Cash Flow
768.8M
↓ 54.33%
Financing Cash Flow
-1.9B
↓ 11.65%
FY20Y/Y Change
Operating Cash Flow
790.5M
↑ 22.92%
Investing Cash Flow
-264.1M
↓ 134.35%
Financing Cash Flow
-440.5M
↓ 76.48%
FY21Y/Y Change
Operating Cash Flow
747.3M
↓ 5.47%
Investing Cash Flow
-231.6M
↓ 12.29%
Financing Cash Flow
-438.3M
↓ 0.51%
FY22Y/Y Change
Operating Cash Flow
611.7M
↓ 18.15%
Investing Cash Flow
-108.0M
↓ 53.39%
Financing Cash Flow
-509.6M
↑ 16.28%
Q1 FY23Q/Q Change
Operating Cash Flow
196.8M
↓ 0.99%
Investing Cash Flow
-34.4M
↓ 68.13%
Financing Cash Flow
-159.2M
↑ 42.86%
Q2 FY23Q/Q Change
Operating Cash Flow
18.1M
↓ 90.79%
Investing Cash Flow
-1.4B
↑ 3872.91%
Financing Cash Flow
1.2B
↓ 827.45%
Q3 FY23Q/Q Change
Operating Cash Flow
157.8M
↑ 771.06%
Investing Cash Flow
-1.4B
↑ 2.74%
Financing Cash Flow
-113.5M
↓ 109.8%

Technicals Summary

Sell

Neutral

Buy

Waters Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Waters Corporation
Waters Corporation
5.93%
5.51%
35.8%
3.55%
60.26%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
7.72%
-3.59%
18.82%
-17.74%
87.1%
Agilent Technologies Inc.
Agilent Technologies Inc.
6.85%
3.3%
34.66%
-2.55%
101.0%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
2.0%
7.39%
23.81%
8.71%
118.65%
Danaher Corp.
Danaher Corp.
5.22%
13.78%
28.89%
-6.88%
100.29%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-4.76%
-2.47%
24.24%
-0.67%
60.64%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Waters Corporation
Waters Corporation
35.95
35.95
3.74
11.6
0.55
0.11
NA
23.79
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
50.12
50.12
5.31
10.54
0.63
0.23
NA
19.16
Agilent Technologies Inc.
Agilent Technologies Inc.
30.87
30.87
3.2
5.24
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
38.42
38.42
2.31
21.73
0.14
0.05
0.0
124.17
Danaher Corp.
Danaher Corp.
51.01
51.01
2.75
7.58
0.08
0.04
0.0
68.92
Iqvia Holdings Inc.
Iqvia Holdings Inc.
30.13
30.13
1.18
11.2
0.23
0.05
NA
36.83
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Waters Corporation
Waters Corporation
Hold
$21.4B
60.26%
35.95
20.71%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$41.6B
87.1%
50.12
22.34%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$42.7B
101.0%
30.87
21.75%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$236.3B
118.65%
38.42
14.69%
Danaher Corp.
Danaher Corp.
Buy
$200.8B
100.29%
51.01
17.83%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$42.2B
60.64%
30.13
9.39%

Insights on Waters Corporation

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 636.83M → 708.52M (in $), with an average increase of 10.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 102.19M → 142.73M (in $), with an average increase of 28.4% per quarter

Institutional Holdings

  • Vanguard Group Inc

    11.83%

  • BlackRock Inc

    9.52%

  • Fundsmith LLP

    6.16%

  • State Street Corp

    4.26%

  • Massachusetts Financial Services Company

    4.07%

  • AllianceBernstein L.P.

    3.97%

Company Information

waters corporation (nyse: wat), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. with approximately 7,000 employees worldwide, waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. waters corporation's businesses include waters, ta instruments, vicam, era, and nonlinear dynamics. waters creates business advantages for laboratory-dependent organizations by delivering ultra performance liquid chromatography (uplc), high-performance liquid chromatography (hplc), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. ta instruments'​ thermal analysis, rheometry

Organization
Waters Corporation
Employees
7900
CEO
Dr. Udit Batra Ph.D.
Industry
Health Technology

Discover More

FAQs